Molecular Characteristics and Clinical Outcomes of EGFR Exon 19 C-Helix Deletion in Non–Small Cell Lung Cancer and Response to EGFR TKIs

Lignende værker

• Molecular Characteristics and Clinical Outcomes of EGFR Exon 19 C-Helix Deletion in Non–Small Cell Lung Cancer and Response to EGFR TKIs
  af: Chun-wei Xu, et al.
  Udgivet: (2020-09-01)
• Molecular characteristics and clinical outcomes of EGFR exon 19 indel subtypes to EGFR TKIs in NSCLC patients
  af: Su, Jian, et al.
  Udgivet: (2017)
• Association of mutant EGFR L858R and exon 19 concentration in circulating cell-free DNA using droplet digital PCR with response to EGFR-TKIs in NSCLC
  af: Zhu, Yan-Juan, et al.
  Udgivet: (2017)
• Pemetrexed-based chemotherapy for non-small-cell lung cancer patients with EGFR exon 20 insertion mutation: a multicenter study
  af: Xu, Chun-Wei, et al.
  Udgivet: (2020)
• Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
  af: Wen, Miaomiao, et al.
  Udgivet: (2018)